Characteristic Clinical Presentations of Tumor Sidedness: Diagnostic & Prognostic Impacts
Guest: Putao Cen, MD Tune in to hear Dr. Putao Cen, Associate Professor of Medical Oncology at the University of Texas Health Science Center McGovern ...
Conversations on Colorectal Cancer
Share:
Listens: 128
About
Between 50 and 60 percent of patients diagnosed with colorectal cancer will develop metastases during the course of their disease, spreading to the lungs, liver, or other secondary location. To help physicians tackle this very real threat facing their patients, Conversations on Colorectal Cancer focuses on the current guidelines and therapeutic landscape for metastatic colorectal cancer (mCRC). This non-certified educational series is sponsored by Lilly. Content for this series is produced and controlled by ReachMD. This series is intended for healthcare professionals only. Sponsored by
Comparing Anti-EGFR in Left vs. Right-Sided Colorectal Cancer Tumors: Survival Trends from the Latest Clinical Trials
Guest: Putao Cen, MD Here to give us a breakdown of what the latest clinical trials are saying about anti-EGFR therapies in left versus right-sided co...
An Oncologist’s Keys to Managing Adverse Events in mCRC Care
Guest: Putao Cen, MD When a patient with metastatic colorectal cancer experiences adverse events like complete obstruction and tumor perforations, it ...
Addressing Gaps in Biomarker Testing for mCRC at Diagnosis
Host: John J. Russell, MD Guest: Axel Grothey, MD Since biomarker testing can aid in the creation of individualized treatment plans, Dr. Axel Grothey ...
Tumor Sidedness in mCRC: Translating the Latest Research Findings into Practice
Host: John J. Russell, MD Guest: Axel Grothey, MD In recent years, researchers have been investigating the role of tumor sidedness in metastatic color...
mCRC ‘State of the Union’: Current & Emerging Research Avenues to Know
Host: John J. Russell, MD Guest: Axel Grothey, MD Since colorectal cancer continues to be one of the most common—and lethal—cancers, it should come as...
Unraveling Disease Progression Predictors of mCRC
Guest: Benjamin A. Weinberg, MD Dr. Benjamin Weinberg, assistant professor at Georgetown University, examines the determinants of disease progression ...
Right-Left Divide: Prognostic Importance of Tumor Sidedness
Guest: Benjamin A. Weinberg, MD Over the years, tumor sidedness has become an area of immense interest for the oncology community. And while they have...
Expanding NCCN Guidelines for mCRC Care
Guest: Benjamin A. Weinberg, MD The NCCN guidelines are the foundation of clinical practice, supporting the decisions of all in the oncology community...
NCCN Guidelines on mCRC in an Era of Tumor Sidedness
Guest: Benjamin A. Weinberg, MD Keeping up with rapid advancements in mCRC, the NCCN updated their guidelines to encompass the perplexity of tumor sid...